期刊文献+

气血葆口服液与阿霉素合用对荷瘤小鼠化疗的增效作用 被引量:4

Qi Xue Bao Kou Fu Ye (Oral Liquid)and Adriamycin for Chemotherapy Synergy in Mice with Tumor
暂未订购
导出
摘要 采用两种荷瘤小鼠 ,灌服气血葆口服液及注射阿霉素 ,观察肿瘤的抑制率和生命延留率。结果表明 ,气血葆口服液可明显提高荷瘤小鼠的肿瘤抑制率和生命延留率 ; Two groups of mice are respectively perfused with the oral liquid and injected with adriamycin,aiming to observe the rate of inhibition and survival. It's shown that this liquid can markedly increase thetwo rates, and that a much better effect is achieved if the liquid and adriamycin are applied simultaneously than when adriamycin is used singly.
出处 《河南中医》 2000年第3期20-21,共2页 Henan Traditional Chinese Medicine
关键词 气血葆口服液 阿霉素 荷瘤小鼠 增效 Qi Xue Bao Kou Fu Ye adriamycin mice with tumor
  • 相关文献

参考文献3

二级参考文献20

共引文献19

同被引文献32

  • 1谭敏,宾晓农,何青莲,刘鹏熙,胥健敏,赵虹,杨海峰.乳腺癌组织中耐药相关基因表达的研究[J].广州中医药大学学报,2005,22(3):200-202. 被引量:7
  • 2宋相容,侯世祥.中药逆转肿瘤多药耐药的研究进展[J].中国中药杂志,2005,30(16):1300-1304. 被引量:13
  • 3周东波,胡成平,苏晓丽,杨红忠.人参单体Rh_2诱导人肺腺癌A549/DDP细胞凋亡的体外研究[J].中国肺癌杂志,2005,8(4):257-260. 被引量:16
  • 4刘鹏熙,陈前军,钟少文,周瑞芳,刘晓雁.新辅助化疗对乳腺癌p170、Ki67、p53的影响[J].肿瘤,2006,26(2):168-170. 被引量:5
  • 5Marnounas EP,Fisher B.Preoperative chemotherapy for operable breast cancer.Cancer Treat Res,2000,103:137-155.
  • 6Sapunar F.Smith IE.Neoadjuvant chemotherapy for breast cancer.Ann Med.2000,32(1):43-50.
  • 7Marnounas EP, Fisher B. Preoperative chemotherapy for operable breast cancer[J].Cancer Treat Res,2000,103: 137-155.
  • 8Sapunar F, Smith IE. Neoadjuvant chemotherapy for breast cancer[J]. Ann Med,2000, 32 (1) : 43-50.
  • 9Bodey B, Bodey BJR,Groger AM,et al. Immunocytochemical detection of the P170 multidrug resistance(MDR) and the P53 tumor suppressor gone protein in humon breast cancer cell. clinical and the therapeutical significance[J].Anticancer Res,1997,17(2B):1311.
  • 10Sun J,He ZG, Cheng G, et al.Multidrug resistance P-glycoprotein crucial significance in drug disposition and interaction[J].Med Sci Monit,2004,10(1):RA5-14.

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部